| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000026411 |
| Receipt No. | R000030241 |
| Scientific Title | Investigation of clinical biomarkers reflecting the neurological basis of depressive symptoms and their usefulness in novel therapeutic technique |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2021/03/09 (Ver. 4) |
| Basic information | ||
| Public title | Investigation of clinical biomarkers reflecting the neurological basis of depressive symptoms and their usefulness in novel therapeutic technique | |
| Acronym | Investigation of clinical biomarkers of depressive symptoms and their usefulness | |
| Scientific Title | Investigation of clinical biomarkers reflecting the neurological basis of depressive symptoms and their usefulness in novel therapeutic technique | |
| Scientific Title:Acronym | Investigation of clinical biomarkers of depressive symptoms and their usefulness | |
| Region |
|
|
| Condition | ||
| Condition | depressive symptoms | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Exploring clinical biomarkers useful for diagnosis and treatment of depressive symptoms. |
| Basic objectives2 | Others |
| Basic objectives -Others | nothing |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Group comparison of psychological examination and brain imaging between psychiatric disorder patients with depressed symptoms and healthy comparison. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | a. or b.
A. Among patients visiting or hospitalized at Gunma University Hospital who has been diagnosed as a corresponding psychiatric disorder in accordance with DSM-5 and has been informed of the disorder or a state. B. Normal people who are free from mental illness and neurological disorder in the present and past. |
|||
| Key exclusion criteria | 1) Under 15 years old
2) Pacemakers, claustrophobia etc. MRI equipment contraindicated 3) Merging serious physical disorders 4) Measures Inpatients 5) Emergency hospitalized patients 6) Others judged inappropriate as subjects by doctors |
|||
| Target sample size | 210 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gunma University Graduate School of Medicine | ||||||
| Division name | Department of Psychiatry and Neuroscience | ||||||
| Zip code | 371-8511 | ||||||
| Address | 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan | ||||||
| TEL | 027-220-8180 | ||||||
| fukuda-psy@gunma-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gunma University Graduate School of Medicine | ||||||
| Division name | Department of Psychiatry and Neuroscience | ||||||
| Zip code | 371-8511 | ||||||
| Address | 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan | ||||||
| TEL | 027-220-8190 | ||||||
| Homepage URL | |||||||
| tyuichi@gunma-u.ac.jp | |||||||
| Sponsor | |
| Institute | Gunma University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Strategic Research Program for Train science |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Gunma University Hospital Clinical Research Review Board |
| Address | showa 3-39-22 |
| Tel | 0272207111 |
| takeiyuichi@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Nothing |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030241 |